AI assistant
Tectonic Therapeutic, Inc. — Director's Dealing 2018
Jun 21, 2018
33251_dirs_2018-06-20_9c009d66-f218-4b78-8bfe-4a286378b67d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AVROBIO, Inc. (AVRO)
CIK: 0001681087
Period of Report: 2018-06-20
Reporting Person: SVLSF VI, LLC (10% Owner)
Reporting Person: SV Life Sciences Fund VI, L.P. (10% Owner)
Reporting Person: SV Life Sciences Fund VI Strategic Partners, L.P. (10% Owner)
Reporting Person: SV Life Sciences Fund VI (GP), L.P. (10% Owner)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series A Preferred Stock | $ | Common Stock (9122809) | Indirect | ||
| Series A Preferred Stock | $ | Common Stock (312341) | Indirect | ||
| Series B Preferred Stock | $ | Common Stock (1808211) | Indirect | ||
| Series B Preferred Stock | $ | Common Stock (61908) | Indirect |
Footnotes
F1: All series of Convertible Preferred Stock shall automatically convert on a 4.132-for-1 basis into shares of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering and have no expiration date.
F2: The shares are held directly by SV Life Sciences Fund VI, L.P. ("SV Life LP"). SV Health Investors, LLC is the Manager of SV Life LP. SV Life Sciences Fund VI (GP), L.P., ("SV Fund VI GP") is the general partner of SV Life LP. The general partner of SV Fund VI GP is SVLSF VI, LLC. The members of the investment committee of SVLSF VI, LLC are Kate Bingham, Thomas Flynn, James Garvey, Eugene D. Hill, III, Paul LaViolette, and Michael Ross. Each of SV Fund VI GP, SVLSF VI, LLC and the SVLSF VI, LLC investment committee disclaims beneficial ownership of the shares owned directly by SV Life LP, except to the extent of any pecuniary interest therein.
F3: The shares are held directly by SV Life Sciences Fund VI Strategic Partners, L.P. ("SV Life SP LP"). SV Health Investors, LLC is the Manager of SV Life SP LP. SV Fund VI GP is the general partner of SV Life SP LP. The general partner of SV Fund VI GP is SVLSF VI, LLC. The members of the investment committee of SVLSF VI, LLC are Kate Bingham, Thomas Flynn, James Garvey, Eugene D. Hill, III, Paul LaViolette, and Michael Ross. Each of SV Fund VI GP, SVLSF VI, LLC and the SVLSF VI, LLC investment committee disclaims beneficial ownership of the shares owned directly by SV Life SP LP, except to the extent of any pecuniary interest therein.